2
2
82
M. J. Laws et al.
H; 5.85, d, J 4.9 Hz, 1H; 6.91, d, J 3.7 Hz, 1H; 7.1–7.3, m, 6H. High-
X-Ray Crystallographic Study
resolution mass spectrum m/z 183.0720 (C
83.0718).
9
H13NOS fragment requires
Data were collected [at 293(2) K] on an Enraf Nonius CAD4
diffractometer; monochromatized Mo Kꢂ (ꢃ 0.71069 Å) radiation was
used, 2° < ꢄ < 50°. Unit cell dimensions were determined from 25 accu-
rately centred reflections 24° < ꢄ < 30°. Three check reflections moni-
tored every 120 min during data collection showed no significant
1
Preparation of N-Isopropylthiophen-2-carboxamide
A mixture of thiophen-2-carboxylic acid (6.51 g, 0.05 mol) and
thionyl chloride (7.3 ml, 0.1 mol) was heated under reflux until the evo-
lution of gas had ceased. The excess thionyl chloride was removed at
reduced pressure and the crude acid chloride was added to a solution of
isopropylamine (6.0 g, 0.1 mol) in dichloromethane (15 ml). The result-
ing solution was stirred at room temperature for 10 h, after which time
21
variation. The structures were solved by direct methods (SHELXS-86)
22
and refined by full-matrix least-squares methods (SHELX-97).
23
Analytical absorption corrections were applied (SHELX-76). Thermal
ellipsoid plots (Fig. 2) were drawn with ZORTEP and represent 30%
24
ellipsoids.
3
it was washed with saturated NaHCO , water and saturated NaCl. The
Crystal data for (7; R = Me).
6 5
C H NOSSe, M 218.1, ortho-
organic layer was dried (MgSO ) and the solvent removed in vacuum.
4
rhombic, space group Pbca, a 8.5098(9), b 11.7147(8), c 14.365(2)
The crude product was recrystallized from ethyl acetate/hexane to
afford the title compound as colourless crystals (6.44 g, 76%), m.p.
3
–1
Å, V 1432.0(3) Å , Z 8, ꢁ 5.46 mm , maximum and minimum trans-
mission 0.48 and 0.44 respectively, 1251 reflections measured (1251
1
8
38–140° (Found: C, 56.7; H, 6.5; N, 8.0. C H11NOS requires C, 56.8;
unique), final R
Crystal data for (7; R = Pr ).
space group P2 /n, a 9.797(2), b 8.872(3), c 21.921(4) Å, ꢆ 99.11(2)°,
1
[I > 2ꢅ(I)] 0.0361, wR
2
0.0774.
1
H, 6.6; N, 8.3%). H n.m.r. ꢀ 1.23, d, 6H, J 6.6 Hz; 4.23, m, 1H; 6.07,
br s, 1H; 7.03, m, 1H; 7.42, dd, 1H, J 5.1, 1.2 Hz; 7.50, dd, 1H, J 3.2,
3
i
8 9
C H NOSSe, M 246.2, monoclinic,
1
1
3
.0 Hz. C n.m.r. ꢀ 22.7, 41.9, 127.4, 129.5, 139.5, 161.1.
3
–1
V 1881.3(8) Å , Z 8 (two molecules per asymmetric unit), ꢁ 4.16 mm ,
maximum and minimum transmission 0.39 and 0.15 respectively, 3309
Preparation of 3,3Ј-Diselenobis(N-alkylthiophen-2-
carboxamides) (13)
reflections measured (3258 unique), final R
1
[I > 2ꢅ(I)] 0.0535, wR
2
0
.1272.
General protocol. To a solution of the N-alkylthiophen-2-carbox-
amide (10.0 mmol) in dry tetrahydrofuran (70 ml) was added a solution
of butyllithium (11 ml, 2.0 M, in cyclohexane). After stirring at 0° for 30
min, finely divided selenium powder (0.79 g, 10.0 mmol) was added in
one portion. The reaction mixture was stirred for 3 h at room tempera-
ture after which time it was poured into a solution of potassium ferri-
cyanide (3.29 g, 10.0 mmol) in water (50 ml) and the mixture stirred
overnight. The mixture was neutralized with 10% HCl and extracted
with dichloromethane (3×). The combined organic layers were dried
Crystal data for (7; R = But).
C H11NOSSe, M 260.2, monoclinic,
9
1
space group P2 /c, a 9.279(2), b 11.795(2), c 19.931(2) Å, ꢆ 90.60(2)°,
3
–1
V 2181.2(6) Å , Z 8 (two molecules per asymmetric unit), ꢁ 3.60 mm ,
maximum and minimum transmission 0.44 and 0.33 respectively, 4073
reflections measured (3820 unique), final R
.0966.
1 2
[I > 2ꢅ(I)] 0.0401, wR
0
Acknowledgments
(
MgSO
4
) and the solvent was removed in vacuum. The residue was sep-
We thank the Australian Research Council for financial
support, and the China Scholarship Council for a scholarship
to S.-L. Zheng.
arated by flash chromatography (1: 4 ethyl acetate/hexane) to afford the
required diselenide (13) of sufficient purity for further use.
3
,3Ј-Diselenobis(N-phenylthiophen-2-carboxamide) (13; R = Ph)
(1.64 g, 58%) had m.p. 233–235° (ethanol/tetrahydrofuran) (Found: C,
4
5
7.0; H, 2.9; N, 5.0. C22
H
16
N
2
O
2
S
2
Se
2
requires C, 47.0; H, 2.9; N,
References
1
.0%). H n.m.r. (Me
2
SO) ꢀ 7.09, m, 1H; 7.34, m, 2H; 7.41, d, 1H, J 3.6
1
7
7
Schewe, T., Gen. Pharmacol., 1995, 26, 1153; Reich, H. J., and
Hz; 7.68, m, 1H; 7.92, d, 1H, J 3.9 Hz; 10.31, br s, 1H. Se n.m.r.
Jasperse, C. P. J., J. Am. Chem. Soc., 1987, 109, 5549; Müller, A.,
Cadenas, E., Graf, P., and Sies, H., Biochem. Pharmacol., 1984, 33,
(
Me
2
SO) ꢀ 509.
,3Ј-Diselenobis(N-t-butylthiophen-2-carboxamide) (13; R = Bu )
1.31 g, 50%) had m.p. 150–153° (Found: C, 41.4; H, 4.7; N, 5.5.
t
3
3
241; Wendel, A., Fausel, M., Safayhi, H., Tiegs, G., and Otter, R.,
(
1
Biochem. Pharmacol., 1984, 33, 3241.
Jacquemin, P. V., Christiaens, L. E., and Renson, M. J., Tetrahedron
Lett., 1992, 33, 3863.
C
18
H
24
N
2
O
2
S
2
Se
2
requires C, 41.4; H, 4.6; N, 5.4%). H n.m.r. ꢀ 1.48, s,
2
3
1
3
1
1
8H; 5.98, br s, 2H; 7.27, m, 4H. C n.m.r. ꢀ 28.9, 52.3, 126.9, 130.0,
32.0, 132.8, 161.7. Se n.m.r. (Me SO) ꢀ 457.
2
7
7
Demello, M. A. R., Flodstrom, M., and Eizirik, D. L., Biochem.
Pharmacol., 1996, 52, 1703; Hattori, R., Yui, Y., Shinoda, E., Inoue,
R., Aoyama, T., Masayasu, H., Kawai, C., and Sasayama, S., Jpn J.
Pharmacol., 1996, 72, 191; Hattori, R., Inoue, R., Sase, K., Eizawa,
H., Kosuga, K., Aoyama, T., Masayasu, H., Kawai, C., Sasayama,
S., and Yui, Y., Eur. J. Pharmacol.—Mol. Pharmacol., 1994, 267,
R1; Zembowicz, A., Hatchett, R. J., Radziszewski, W., and
Gryglewski, R. J. J., J. Pharmacol. Exp. Ther., 1993, 267, 1112.
Cembrzynskanowak, M., Szklarz, E., and Inglot, A. D., Interferon
Cytokine Res., 1997, 17, 609; Tiegs, G., Kusters, S., Kunstle, G.,
Hentze, H., Kiemer, A. K., and Wendel, A. J., J. Pharmacol. Exp.
Ther., 1998, 287, 1098; Gao, J. X., and Issekutz, A. C., Int. J.
Immunopharmacol., 1994, 16, 279.
Preparation of 2-Alkylthieno[2,3-d]isoselenazol-3(2H)-ones (7)
General protocol. The required crude diselenide (13) (1.0 mmol)
and benzoyl peroxide (0.35 g, 1.1 mmol) were heated to reflux under
nitrogen until t.l.c. indicated the absence of starting material. The reac-
tion mixture was diluted with dichloromethane and then washed with
3
saturated NaHCO and saturated NaCl. The organic layer was dried
(
MgSO ) and the solvent removed in vacuum. The residue was purified
4
4
by flash chromatography (2: 3 ethyl acetate/hexane) to afford the title
compounds as crystalline solids as described below.
t
2
-t-Butylthieno[2,3-d]isoselenazol-3(2H)-one (7; R = Bu ) (0.38 g,
7
3%) had m.p. 195–196° (Found: C, 41.5; H, 4.2; N, 5.4. C
9
H
11NOSSe
1
requires C, 41.5; H, 4.3; N, 5.4%). H n.m.r. ꢀ 1.65, s, 9H; 7.16, d, 1H,
J 5.0 Hz; 7.64, d, 1H, J 5.0 Hz. C n.m.r. ꢀ 28.9, 59.4, 121.7, 130.2,
1
5
6
7
1
3
Anon., Drugs Future, 1995, 20, 1057.
Fong, M. C., and Schiesser, C. H., J. Org. Chem., 1997, 62, 3103.
Fong, M. C., Laws, M. J., and Schiesser, C. H., Aust. J. Chem.,
7
7
33.5, 136.4, 163.0. Se n.m.r. ꢀ 901.
-Isopropylthieno[2,3-d]isoselenazol-3(2H)-one (7;
Pri)
2
R =
1
995, 48, 1221.
(
0.32 g, 65%) had m.p. 139–140° (Found: C, 39.0; H, 3.7; N, 5.6.
8
9
0
1
Esker, J. L., and Newcomb, M., J. Org. Chem., 1994, 59, 2779.
Angus, J. A., Schiesser, C. H., and Venn, M. K., unpublished data.
Engman, L., Laws, M. J., Malmström, J., Schiesser, C. H., and
Zugaro, L. M., J. Org. Chem., 1999, 64, 6764.
Eur. Pat. EP44971; U.S. Pat. 4352799; Ger. Pats DE3515272,
DE3515273.
8 9
C H NOSSe requires C, 39.0; H, 3.7; N, 5.7%). H n.m.r. ꢀ 1.36, d, 6H,
1
3
J 5.4 Hz; 4.68, m, 1H; 7.39, d, 1H, J 4.8 Hz; 7.67, d, 1H, J 4.8 Hz.
C
1
n.m.r. ꢀ 22.2, 45.5, 123.1, 127.0, 131.5, 138.8, 161.5. 77Se n.m.r. ꢀ 888.
2
-Methylthieno[2,3-d]isoselenazol-3(2H)-one (7; R = Me) (0.05 g,
0%) had m.p. 245–247° (Found: C, 33.0; H, 2.3; N, 6.5. C NOSSe
requires C, 33.0; H, 2.3; N, 6.4%). H n.m.r. ꢀ 3.27, s, 3H; 7.37, d, 1H,
11
1
6 5
H
1
1
2
1
3
Lambert, C., Hilbert, M., Christiaens, L., and Dereu, N., Synth.
Commun., 1991, 21, 85.
J 4.8 Hz; 7.84, d, 1H, J 4.8 Hz. C n.m.r. ꢀ 31.17, 124.6, 126.9, 132.5,
7
7
1
40.6, 163.1. Se n.m.r. ꢀ 925.